Carregant...
Pretreatment with Bone Marrow Derived Mesenchymal Stromal Cell Conditioned Media Confers Pulmonary Ischemic Tolerance
OBJECTIVE: Mesenchymal stromal cell based therapies have demonstrated efficacy in treating a variety of diseases. Despite the potential benefits, there are still significant hurdles that need to be overcome for clinical use. We describe a cell-free based immunotherapy approach for inducing pulmonary...
Guardat en:
| Publicat a: | J Thorac Cardiovasc Surg |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4761408/ https://ncbi.nlm.nih.gov/pubmed/26896360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2015.11.043 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|